Drug Shortage Report for APO-DILTIAZ CD

Last updated on 2020-11-27 History
Report ID 128594
Drug Identification Number 02230998
Brand name APO-DILTIAZ CD
Common or Proper name DILTIAZ CD
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) DILTIAZEM HYDROCHLORIDE
Strength(s) 180MG
Dosage form(s) CAPSULE (CONTROLLED-DELIVERY)
Route of administration ORAL ORAL
Packaging size 500 BTL
ATC code C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-11-16
Estimated end date 2020-11-29
Actual end date 2020-11-24
Shortage status Resolved
Updated date 2020-11-27
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-11-27 French Compare
v3 2020-11-27 English Compare
v2 2020-11-19 French Compare
v1 2020-11-19 English Compare